Dialysis patients and their families are continuing to join the federal GranuFlo lawsuit litigation now underway in the U.S. District Court, District of Massachusetts, according to a recent Case List update.

A docket report issued February 19th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) indicates that 515 cases alleging injuries caused by GranuFlo and NaturaLyte have now been filed over a pair of medications recalled in June 2012. These lawsuits, which blame Fresenius Medical Care for heart attacks, sudden cardiac death and other cardiovascular injuries, have been consolidated for pretrial proceedings in Massachusetts federal court. When this federal multidistrict litigation was first created almost a year ago, only 11 cases had been filed.

500+ GranuFlo Recall Lawsuits Filed in Two-Year Period

Side effects associated with GranuFlo and NaturaLyte may be caused by the medication’s high amount of an ingredient the body converts to bicarbonate, lawsuits allege, which may result in a condition known as metabolic alkalosis. In turn, this may lead to serious and life-threatening cardiovascular injuries within 72 hours of the drugs’ administration. According to plaintiffs, Fresenius Medical Care failed to warn patients and their doctors about the risks associated with GranuFlo and NaturaLyte prior to issuing an Urgent Product Notification in March 2012. The notice was given Class I recall status by the U.S. Food and Drug Administration (FDA) two months later after it was determined that the risk for cardiac arrhythmia, cardiac arrest and other side effects may be serious, and potentially fatal.

Lawsuits allege that Fresenius may have had knowledge of these risks that they concealed, after finding an internal memo sent by the company in November 2011 that acknowledged 941 patient deaths stemming from use of the medications. At this time, doctors operating within the Fresenius network were advised to adjust dosages of GranuFlo and NaturaLyte to prevent further casualties. Physicians operating in more than 125,000 customer clinics outside the company’s network were not warned about these side effects until several months after.

In addition to GranuFlo and NaturaLyte recall lawsuits in Massachusetts federal court, a number of cases are pending in a state litigation established in Middlesex County Superior Court.

Filing a GranuFlo Recall Lawsuit

To join the growing litigation of lawsuits filed in the wake of 2012’s GranuFlo recall, contact the lawyers at Bernstein Liebhard LLP for a free evaluation of your case. Call us now at (877) 779-1414.

Published February 24, 2014 by